<DOC>
	<DOCNO>NCT01659307</DOCNO>
	<brief_summary>This double-blind , placebo-controled , randomized trial investigate aspirin pre-treatment anti-inflammatory effect model acute lung injury induce inhaled endotoxin ( LPS ) healthy human volunteer .</brief_summary>
	<brief_title>The Effect Aspirin REducing iNflammation Human Vivo Model Acute Lung Injury</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Acute Lung Injury</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Lung Injury</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Healthy subject Age &lt; 18 year Pregnancy breast feed woman childbearing potential use adequate contraception . Participation clinical trial investigational medicinal product within 30 day Consent decline Aspirin non steroidal antiinflammatory ( NSAID ) use past 4 week History asthma Known aspirin NSAID hypersensitivity History peptic ulcer disease Platelet count &lt; 150 x 106/ml Aspirin resistance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Acute Lung Injury</keyword>
	<keyword>Acute Respiratory Distress Syndrome</keyword>
	<keyword>Aspirin</keyword>
</DOC>